Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons
Andreas Leffler, … , Peter W. Reeh, Carla Nau
Andreas Leffler, … , Peter W. Reeh, Carla Nau
Published January 2, 2008
Citation Information: J Clin Invest. 2008;118(2):763-776. https://doi.org/10.1172/JCI32751.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 1

The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons

  • Text
  • PDF
Abstract

Local anesthetics (LAs) block the generation and propagation of action potentials by interacting with specific sites of voltage-gated Na+ channels. LAs can also excite sensory neurons and be neurotoxic through mechanisms that are as yet undefined. Nonspecific cation channels of the transient receptor potential (TRP) channel family that are predominantly expressed by nociceptive sensory neurons render these neurons sensitive to a variety of insults. Here we demonstrated that the LA lidocaine activated TRP channel family receptors TRPV1 and, to a lesser extent, TRPA1 in rodent dorsal root ganglion sensory neurons as well as in HEK293t cells expressing TRPV1 or TRPA1. Lidocaine also induced a TRPV1-dependent release of calcitonin gene–related peptide (CGRP) from isolated skin and peripheral nerve. Lidocaine sensitivity of TRPV1 required segments of the putative vanilloid-binding domain within and adjacent to transmembrane domain 3, was diminished under phosphatidylinositol 4,5-bisphosphate depletion, and was abrogated by a point mutation at residue R701 in the proximal C-terminal TRP domain. These data identify TRPV1 and TRPA1 as putative key elements of LA-induced nociceptor excitation. This effect is sufficient to release CGRP, a key component of neurogenic inflammation, and warrants investigation into the role of TRPV1 and TRPA1 in LA-induced neurotoxicity.

Authors

Andreas Leffler, Michael J. Fischer, Dietlinde Rehner, Stephanie Kienel, Katrin Kistner, Susanne K. Sauer, Narender R. Gavva, Peter W. Reeh, Carla Nau

×

Figure 1

Lidocaine induces an increase of [Ca2+]i and inward currents in DRG neurons.

Options: View larger image (or click on image) Download as PowerPoint
Lidocaine induces an increase of [Ca2+]i and inward currents in DRG neur...
(A) Representative experiment showing increasing changes in fluorescence ratios F340/F380 with increasing concentrations of lidocaine in a capsaicin-sensitive rat DRG neuron. Cells were treated with increasing concentrations of lidocaine for 40 s in intervals of 4 min. After lidocaine treatment, cells were subsequently treated with 1 μM capsaicin. (B) Dose-response curve for lidocaine-evoked [Ca2+]i rise in rat DRG neurons. Due to an incomplete recovery of responses to 30 and 100 mM, 2 independent sets of experiments were used to compile the dose-response curve: 0.3, 1, 3, and 30 mM (n = 65) and 0.1, 3, 10, and 100 mM (n = 64). The data were fitted to the Hill equation. (C) Cell diameter of rat DRG neurons that were sensitive or insensitive to lidocaine and capsaicin. (D) Representative inward currents activated by lidocaine (30 mM) and capsaicin (1 μM) and the effect of PMA on lidocaine-evoked currents in rat DRG neurons. Cells were held at –60 mV, and test solutions were applied in intervals of 3 min. (E) Changes in fluorescence ratios F340/F380 in a capsaicin-sensitive and -insensitive mouse DRG neuron. Cells were treated with 30 mM lidocaine (30 s), 1 μM capsaicin (10 s), and 40 mM KCl (10 s) in intervals of 3 minutes. Only cells displaying a clear response to KCl were included in the analysis. (F) Mean changes in fluorescence ratios [Δratio (F340/F380)] induced by 30 mM lidocaine in mouse WT and TRPV1–/– DRG neurons (unpaired Student’s t test). The designation “all” denotes all neurons of the respective genotype that were examined. WT neurons were divided into 2 categories, capsaicin sensitive (Cap+) and insensitive (Cap–). (G) Mean current amplitudes evoked by 30 mM lidocaine in mouse WT (n = 49) and TRPV1–/– (n = 35) neurons. WT neurons were divided into capsaicin-sensitive and -insensitive neurons. Both WT and TRPV1–/– neurons were divided into acrolein-sensitive (Acro+) and -insensitive (Acro–) neurons (unpaired Student’s t test). Neurons that neither responded to lidocaine (30 mM), nor capsaicin (1 μM), nor acrolein (100 μM) (WT, 12 of 49; TRPV1–/–, 12 of 35) were included. (H) Area-proportional Venn diagram to represent the fraction of WT or TRPV1–/– neurons responding to 1, 2, or 3 of the substances lidocaine, capsaicin, and acrolein. Cells responding to none of the substances were excluded. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
134 readers on Mendeley
4 readers on CiteULike
See more details